Pathophysiology of Coronary Microvascular Dysfunction
Authors:
Top Cited Papers
Open Access
- 25 August 2022
- journal article
- review article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 86 (9) , 1319-1328
Abstract
Ischemic heart disease (IHD) is commonly recognized as the consequence of coronary atherosclerosis and obstructive coronary artery disease (CAD). However, a significant number of patients may present angina or myocardial infarction even in the absence of any significant coronary artery stenosis and impairment of the coronary microcirculation has been increasingly implicated as a relevant cause of IHD. The term “coronary microvascular dysfunction” (CMD) encompasses several pathogenic mechanisms resulting in functional and/or structural changes in the coronary microcirculation and determining angina and myocardial ischemia in patients with angina without obstructive CAD (“primary” microvascular angina), as well as in several other conditions, including obstructive CAD, cardiomyopathies, Takotsubo syndrome and heart failure, especially the phenotype with preserved ejection fraction. The pathogenesis of CMD is complex and involves the combination of functional and structural alterations leading to impaired coronary blood flow and resulting in myocardial ischemia. In the absence of therapies specifically targeting CMD, attention has been focused on the role of modifiable risk factors. Here, we provide updated evidence regarding the pathophysiological mechanisms underlying CMD, with a particular focus on the role of cardiovascular risk factors and comorbidities. Moreover, we discuss the specific pathogenic mechanisms of CMD across the different cardiovascular diseases, aiming to pave the way for further research and the development of novel strategies for a precision medicine approach.Keywords
This publication has 58 references indexed in Scilit:
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal, 2013
- High Prevalence of a Pathological Response to Acetylcholine Testing in Patients With Stable Angina Pectoris and Unobstructed Coronary ArteriesJACC, 2012
- Increased availability of angiotensin AT1 receptors leads to sustained arterial constriction to angiotensin II in diabetes – role for Rho‐kinase activationBritish Journal of Pharmacology, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo SyndromeEuropean Heart Journal, 2010
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Advanced Glycation End ProductsCirculation, 2006
- Deletion of p66 shc Gene Protects Against Age-Related Endothelial DysfunctionCirculation, 2004
- Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded RatsCirculation, 2002
- Vasotonic angina: A spectrum of ischemic sysdroms involving function abnormalities of the epicardial and microvascular coronary circulationJACC, 1993